Partnerships in Developing New JM Treatments
In October, Cure JM had two speakers give an update about drug discovery in juvenile myositis.
In October, Cure JM had two speakers give an update about drug discovery in juvenile myositis.
Learn about IVIG (immunoglobulin therapy administered by vein). This session features Dr. Fatma Dedeoglu of Boston Children’s Hospital, Huub Kreuwel PhD, of Octapharma Plasma, and patient advocate, Michelle Vogel, of CSI Pharmacy.
There is no excerpt because this is a protected post.
Membership is free and we’ll connect you with a network of support, encouragement, and resources.
To have your fundraiser matched, add “DIY Match” in the memo of your online gift or check.